Recursion Pharmaceuticals beat estimated earnings by 30.0%, reporting an EPS of $-0.21 versus an estimate of $-0.3. Revenue was up $30.99 million from the same period last year. During the previous ...

Based on the one-year price targets offered by 7 analysts, the average target price for Recursion Pharmaceuticals Inc (NASDAQ:RXRX) is $7.00, with a high estimate of $11.00 and a low estimate of $3.00 ...

Blockchain technology continues to evolve rapidly with scalability and efficiency as key challenges. Recursive SNARKs (Succinct Non-Interactive Arguments of Knowledge) have emerged as a breakthrough ...

Recursion Pharmaceuticals (RXRX) closed at $3.42 in the latest trading session, marking a -8.06% move from the prior day. The stock trailed the S&P 500, which registered a daily gain of 0.69%.

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Recursion Pharmaceuticals ...

Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.85, moving -3.27% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.33%. On ...

The Gordie Howe International Bridge, expected to open early this year, was built by Canada to ease cargo transport between Detroit and Windsor, Ontario. By Chris Cameron and Vjosa Isai Chris Cameron ...

Among the two rumored flavors, Qualcomm is expected to bring LPDDR6 RAM and a full-fledged GPU for only the Snapdragon 8 Elite Gen 6 Pro. A newly leaked block diagram now suggests the Pro chip may ...